Related Experiment Video
Updated: Jun 13, 2026

07:56
Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
Published on: November 11, 2020
Metered-dose inhaler efficiency enhancement: a case study and novel design
Ahmed Fadl1, Jinbo Wang, Zongqin Zhang
1Department of Mechanical Engineering and Applied Mechanics, University of Rhode Island, Kingston, RI 02881,USA. fadla@egr.uri.edu
Inhalation Toxicology
|April 15, 2010
Summary
Researchers improved metered-dose inhaler (MDI) efficiency by adding a wire jet depressor to the mouthpiece. This modification reduces aerosol loss in the mouth, enhancing drug delivery for respiratory patients.
Area of Science:
- Aerosol science and pharmaceutical technology.
Background:
- Metered-dose inhalers (MDIs) are crucial for delivering medication to patients with lung diseases.
- Inhaler efficiency is often limited by aerosol deposition in the oral airway due to inertial impaction.
Purpose of the Study:
- To investigate a novel mouthpiece modification for enhancing MDI aerosol penetration efficiency.
- To reduce inertial impaction losses within the MDI mouthpiece.
Main Methods:
- A wire-based jet depressor (0.5 mm diameter) was inserted 2 mm in front of the MDI nozzle in modified mouthpieces (16 and 20 mm).
- Aerosol penetration efficiency was measured using modified and conventional mouthpieces.
- Experiments were conducted at varying airflow rates (30, 60, 90 L/min) and entrance angles (0-40 degrees).
- Aerosol impaction strength was also evaluated.
Main Results:
- The modified mouthpiece demonstrated significantly higher aerosol penetration efficiency compared to the conventional mouthpiece.
- The wire-based jet depressor effectively reduced inertial impaction.
Conclusions:
- The novel wire-based jet depressor modification offers a simple and effective method to improve MDI performance.
- Enhanced aerosol delivery efficiency can lead to better therapeutic outcomes for patients using MDIs.
Related Concept Videos
Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

